Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: The San Antonio heart study

Diabetes Care

Volumn 21, Issue 7, 1998, Pages 1167-1172

  Wei, Ming ^a   Gaskill, Sharon P ^b   Haffner, Steven M ^b   Stern, Michael P ^b  

^a Division of Epidemiology and Clinical Applications   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; SEX DIFFERENCE;

ACTIVITIES OF DAILY LIVING; ADULT; ANIMALS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MEXICAN AMERICANS; MICROVASCULAR ANGINA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; SURVIVAL ANALYSIS; TEXAS; TIME FACTORS; TRIGLYCERIDES;

EID: 0031848378     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.7.1167     Document Type: Article

References (28)

1. Geiss LS, Herman WH, Smith PJ: Mortality in non-insulin-dependent diabetes. In Diabetes in AmeKurdistanrica. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt Printing Office, 1995, p. 233-257 (NIH Publ. no. 95-1468)
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
3. Wei M, Mitchell BD, Haffner SM, Stern MP: The effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 144:1058-1065, 1996
4. West KM, Ahuja MM, Bennett PH, Czyzyk A, De Acosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Krolewski AS, Miki E, Schliack V, Teuscher A, Watkins PJ, Stober JA: The role of circulating glucose and triglycrride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study Diabetes Care 6:361-369, 1983
5. Kuusisto J, Mykkänen L, Pyörölä K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
6. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46:1354-1359, 1997
7. Laakso M, Kuusisto J: Epidemiological evidence for the association of hyperglycemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 28:415-418, 1996
8. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
9. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
10. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP: Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 14:102-108, 1991
11. Haffner SM, Morales PA, Hazuda HP, Stern MP: Level of control of hypertension in Mexican Americans and non-Hispanic whites. Hypertension 21:83-88, 1993
12. Stern MP, Mitchell BD: Diabetes in Hispanic Americans. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt Printing Office, 1995, p. 631-655 (NIH Publ. no. 95-1468)
13. Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler CW, Rosenthal M: A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodologic findings from the San Antonio Heart Study. Am J Epidemiol 123:96-112, 1986
14. World Health Organization: Second Report on Diabetes Mellitus. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
15. Cox DR; Regression models and life-tables. J R Stat Soc (B) 34:187-220, 1972
16. Greenland S: Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340-349, 1989
17. Wei M, Homung CA: Depression and survival following myocardial infarction (Letter). JAMA 271:1080, 1994
18. Stern MP: Glycemia and cardiovascular risk (Editorial). Diabetes Care 20:1501-1502, 1997
19. Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835-1843, 1992
20. Vlassara H, Bucala R: Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors. Diabetes 45 (Suppl. 3):S65-S66, 1996
21. Bucala R, Makita Z, Koschinsky T, Cerami A: Lipid advanced glycosylation: pathway for lipid oxidation in vivo, Proc Natl Acad Sci U S A 90:6434-6438, 1993
22. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H: Modification of LDL by advanced glycosylation endproducts contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci U S A 91:9441-9445, 1994
23. Steinberg D, Parthasarathy S, Carew TE, Khou JC, Witztum JL: Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 320:913-924, 1989
24. Stout RW: Insulin and atheroma, 20-yr perspe spcctivc. Diabetes Care 13:631-654, 1990
25. Stern MP: The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes. Arch Fam Med 7:155-162, 1998
26. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
27. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KGMM: Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol 144:224-234, 1996
28. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH: A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 20:935-942, 1997